Company Information

Revenue, expenses and profitability over five years.

Income Statement

BALAXI PHARMACEUTICALS LTD.

NSE Code
BALAXIEQ
BSE Code
-
ISIN
INE618N01022
Industry
Trading
Financial Data

Income Statement

All amounts are in ₹ crore unless stated otherwise.

Showing Standalone data

Table can be scrolled horizontally on smaller screens.

Five-year standalone Income Statement for the selected company
ParticularsMar 26Mar 25Mar 24Mar 23Mar 22
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue2.002.0010.0010.0010.00
INCOME
Revenue From Operations [Net]80.8560.9970.20108.14101.29
Total Operating Revenues80.8560.9970.20108.14101.29
Other Income9.675.372.406.602.75
Total Revenue90.5266.3672.59114.74104.04
EXPENSES
Cost Of Materials Consumed69.1150.9456.4982.1076.92
Employee Benefit Expenses6.004.875.044.042.90
Finance Costs2.702.061.540.460.06
Depreciation And Amortisation Expenses0.700.460.510.520.25
Other Expenses4.972.753.435.184.21
Total Expenses83.4961.0767.0192.2984.34
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax7.035.295.5822.4519.70
Profit/Loss Before Tax7.035.295.5822.4519.70
Tax Expenses-Continued Operations
Current Tax1.451.782.045.175.00
Deferred Tax0.43-0.10-0.111.060.03
Total Tax Expenses1.891.691.936.235.03
Profit/Loss After Tax And Before ExtraOrdinary Items5.153.603.6516.2214.67
Profit/Loss From Continuing Operations5.153.603.6516.2214.67
Profit/Loss For The Period5.153.603.6516.2214.67
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)0.930.653.5516.1714.67
Diluted EPS (Rs.)0.930.653.5416.0214.67
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend0.000.000.000.500.00

Source: Financial statements as reported by the company.